Retrieve available abstracts of 41 articles: HTML format
Single Articles
July 2025
STOOP TF, Rompen IF, Ali M, Groot Koerkamp B, et al Resectability stages of pancreatic cancer: nationwide reference.
Br J Surg. 2025;112:znaf120. PubMed
April 2025
ADACHI Y, Okabe H, Hayashi H, Tagayasu Y, et al Round ligament coverage with polyglycol acid mesh and fibrin glue on pancreatic
stump may decrease postoperative pancreatic fistula in distal pancreatectomy.
Br J Surg. 2025;112:znaf101. PubMed
FRANCKEN MFG, Boxhoorn L, van Dijk SM, van Grinsven J, et al Cost-effectiveness of immediate versus postponed intervention for infected
necrotizing pancreatitis: planned secondary analysis of the POINTER trial.
Br J Surg. 2025;112:znaf071. PubMed
VAN VELDHUISEN CL, Leseman CA, De Rijk FEM, Marques-Antunes J, et al Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre
study.
Br J Surg. 2025;112:znaf068. PubMedAbstract available
TANAKA H, Sakai A, Suenaga M, Hayashi M, et al FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in
preoperative therapy for pancreatic cancer: multicentre retrospective study
(GEMINI-PC-01).
Br J Surg. 2025;112:znaf049. PubMed
LIN H, Ning J, Liu Q, Du X, et al Application of transmesocolon pancreatic intestinal anastomosis in
duodenal-preserving pancreatic head resection: video article.
Br J Surg. 2025;112:znaf084. PubMed
BONSDORFF A, Kjeseth T, Kirkegard J, de Ponthaud C, et al International multicentre validation of the left pancreatectomy pancreatic
fistula prediction models and development and validation of the combined
DISPAIR-FRS prediction model.
Br J Surg. 2025;112:znae313. PubMedAbstract available
February 2025
SHIRAISHI Y, Hayashi H, Liu Z, Schrader J, et al YAP/TAZ overexpression activates mTOR and Erk1/2 signalling and is associated
with worse outcomes for patients with pancreatic neuroendocrine neoplasms.
Br J Surg. 2025;112:znaf006. PubMed
VAN SANTVOORT H, Voermans RP, Zyromski NJ, Siriwardena AK, et al Antibiotic stewardship in acute pancreatitis.
Br J Surg. 2025;112:znaf007. PubMed
WISMANS LV, Hendriks TE, Suurmeijer JA, Nuyttens JJ, et al Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk
patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre
phase II single-arm trial.
Br J Surg. 2025;112:znae327. PubMedAbstract available
DEKKER EN, van Klaveren D, Verkolf EMM, de Wilde RF, et al Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for
locally advanced pancreatic cancer identifies patients who may benefit from
surgical exploration: multicentre, observational cohort study.
Br J Surg. 2025;112:znaf011. PubMedAbstract available
KLEIVE D Reducing pancreatic fistula after left-sided pancreatectomy-the search continues.
Br J Surg. 2025;112:znaf033. PubMed
SUMIYOSHI T, Uemura K, Seo S, Fujii T, et al Impact of pre-compression versus non-compression before parenchyma transection in
left-sided pancreatic resection on the rate of clinically relevant pancreatic
fistula: multicentre randomized clinical trial.
Br J Surg. 2025;112:znaf008. PubMedAbstract available
December 2024
DENG Z, Lan Z, Zhu H, Ren H, et al Metagenomic next-generation sequencing for the detection of bacterial
translocation in the blood of patients following liver, biliary tract or
pancreatic surgery.
Br J Surg. 2024;112:znae326. PubMed
October 2024
LUCOCQ J, Pandanaboyana S Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN):
emerging data warrants further research.
Br J Surg. 2024;111:znae238. PubMed
DEKKER EN, Narayan RR, Ahmami MA, Meddouch A, et al Chemotherapy switch for localized pancreatic cancer: a systematic review and
meta-analysis.
Br J Surg. 2024;111:znae244. PubMedAbstract available
August 2024
PARTELLI S, Landoni L, Bartolomei M, Zerbi A, et al Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours
(NEOLUPANET): multicentre phase II study.
Br J Surg. 2024;111:znae178. PubMedAbstract available
HALLET J, Soreide K Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic
neuroendocrine tumours.
Br J Surg. 2024;111:znae183. PubMed
BRUNA CL, van Hilst J, Esposito A, Kleive D, et al The value of splenectomy during left-sided pancreatectomy for pancreatic ductal
adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial.
Br J Surg. 2024;111:znae236. PubMed
SOREIDE K, Barreto SG, Pandanaboyana S Severe acute pancreatitis.
Br J Surg. 2024;111:znae170. PubMed
May 2024
SISSINGH NJ, de Rijk FEM, Timmerhuis HC, Umans DS, et al Gallstones as a cause in presumed acute alcoholic pancreatitis: observational
multicentre study.
Br J Surg. 2024;111:znae107. PubMedAbstract available
April 2024
UNDERWOOD PW, Cloyd JM Comment on: Predictive value of baseline serum carbohydrate antigen 19-9 level on
treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and
borderline resectable pancreatic cancer in two randomized trials.
Br J Surg. 2024;111:znae085. PubMed
VAN RAMSHORST TME, van Hilst J, Boggi U, Dokmak S, et al Standardizing definitions and terminology of left-sided pancreatic resections
through an international Delphi consensus.
Br J Surg. 2024;111:znae039. PubMed
ANDREASI V, Partelli S, Schiavo Lena M, Muffatti F, et al Prognostic significance of nodal micrometastases of non-functioning pancreatic
neuroendocrine tumours.
Br J Surg. 2024;111:znae076. PubMed
March 2024
THEIJSE RT, Stoop TF, Janssen QP, Prakash LR, et al Impact of a non-therapeutic laparotomy in patients with locally advanced
pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic
Surgery (TAPS) Consortium study.
Br J Surg. 2024;111:znae033. PubMedAbstract available
IMAMURA T, Ashida R, Urakami K, Ohshima K, et al Comprehensive sequencing of circulating tumour DNA in resectable pancreatic
cancer.
Br J Surg. 2024;111:znae059. PubMed
January 2024
VAN BEEK DJ, Van Den Heede K, Rinkes IB, Norlen O, et al Surgery for advanced pancreatic neuroendocrine neoplasms: recommendations based
on a consensus meeting of the European Society of Endocrine Surgeons (ESES).
Br J Surg. 2024;111:znae017. PubMed
LARSSON P, Soreide K Surgery for oligometastatic pancreatic cancer: next frontier?
Br J Surg. 2024;111:znad419. PubMed
OMIYA K, Maekawa A, Oba A, Inoue Y, et al A proposal of ABCD metastasectomy criteria for synchronous/metachronous
metastatic pancreatic cancer in the era of multidisciplinary treatment.
Br J Surg. 2024;111:znad417. PubMed
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67
countries.
Br J Surg. 2024;111:znad330. PubMedAbstract available
December 2023
ONNEKINK AM, Michiels N, Klatte DCF, Oldenburg L, et al Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16
pathogenic variant under surveillance.
Br J Surg. 2023 Dec 29:znad430. doi: 10.1093. PubMed
HALL LA, Powell-Brett S, Halle-Smith J, Ward L, et al Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal
surgery: meta-analysis.
Br J Surg. 2023 Dec 8:znad369. doi: 10.1093. PubMedAbstract available
November 2023
KIRKEGARD J, Ladekarl M, Johannsen IR, Mortensen F, et al Effect of adjuvant chemotherapy after pancreatectomy in patients with
node-negative pancreatic cancer: target trial emulation.
Br J Surg. 2023 Nov 25:znad398. doi: 10.1093. PubMedAbstract available
SCHLAPFER M, Schadde E, Braun J, Soll C, et al Effect of volatile versus total intravenous anaesthesia on circulating tumour
cells after pancreatic adenocarcinoma resection: multicentre randomized clinical
trial.
Br J Surg. 2023 Nov 14:znad357. doi: 10.1093. PubMed
October 2023
BOAG KF, Britton E, Knight SR, Coe PO, et al Definition and management of intra-abdominal metachronous oligometastatic
pancreatic cancer: a systematic review.
Br J Surg. 2023 Oct 31:znad338. doi: 10.1093. PubMed
UMANS DS, Timmerhuis HC, Anten MGF, Bhalla A, et al Prospective multicentre study of indications for surgery in patients with
idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS).
Br J Surg. 2023 Oct 9:znad318. doi: 10.1093. PubMedAbstract available
July 2023
DOPPENBERG D, van Dam JL, Han Y, Bonsing BA, et al Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment
effect of neoadjuvant chemoradiotherapy in patients with resectable and
borderline resectable pancreatic cancer in two randomized trials.
Br J Surg. 2023 Jul 13:znad210. doi: 10.1093. PubMedAbstract available
June 2023
STRAND K, Moller JH Fluid treatment in acute pancreatitis: a careful balancing act.
Br J Surg. 2023 Jun 16:znad155. doi: 10.1093. PubMed
MAGGINO L, Malleo G, Crippa S, Belfiori G, et al Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer:
implications for adjuvant therapy.
Br J Surg. 2023 Jun 1:znad146. doi: 10.1093. PubMedAbstract available
AMMER-HERRMENAU C, Lingens CHM, Ratei CS, Heuer C, et al Whole 16S rRNA sequencing of the oral microbiome predicts postoperative
pancreatic fistula: prospective observational cohort study.
Br J Surg. 2023 Jun 1:znad129. doi: 10.1093. PubMed